2024:

A total of 7 meetings of the board of directors were held in 2024. Director attendance was as follows:

Title

Name

Attendance

in Person

By Proxy

Attendance rate (%)

Remark

Chairman

Wang, Shih-Chung

7

0

100%

Renewal of office

Director

Lan, Shun-Cheng

7

0

100%

Renewal of office

Director

Wang, Hai-Ming

7

0

100%

Renewal of office

Director

Chen, Jui-Lung

7

0

100%

Renewal of office

Director

Li, Huai-Wen

7

0

100%

Renewal of office

Director

Tsao, Yung-Hsiang

7

0

100%

Renewal of office

Independent director

Renn, Jyh-Chyang

7

0

100%

Renewal of office

Independent director

Lin, Yu-Ya

7

0

100%

Renewal of office

Independent director

Lin, Ken-Mao

7

0

100%

New office assumed

Independent director

Huang, Yi-Wen

7

0

100%

New office assumed

Notes:

1. If any of the following circumstances occur, the dates of meetings, sessions, contents of motions, all independent directors’ opinion and the Company’s response to independent directors’ opinion should be specified:

(1) Matters referred to in Article 14-3 of the Securities and Exchange Act.

Not applicable. The Company has already established an audit committee.

(2) Other matters involving objections or expressed by independent directors that were recorded in writing that require a resolution by the board of directors: None.

2. If there is Directors’ avoidance of motions in conflict of interest, the Directors’ names, contents of motions, causes for avoidance and voting should be specified:

The tenth meeting of the board of directors of the sixth term propose to adjust the position and remuneration adjustment for Li, Huai-Wen, the Vice General Manager of the Company and the General Manager of Mainland China Business Group. The Director, Li, Huai-Wei, who has a personal interest in the matter under discussion at a meeting of the directors, shall not exercise voting rights nor exercise voting rights on behalf of another director due to conflict of interest. The tenth meeting of the board of directors propose to adjust the position and remuneration adjustment for Tsao, Yung-Hsiang, the Chief Financial Officer of the Company. The Director, Tsao, Yung-Hsiang, who has a personal interest in the matter under discussion at a meeting of the directors, shall not exercise voting rights nor exercise voting rights on behalf of another director due to conflict of interest.

3. Measures taken to strengthen the functionality and performance assessment of the Board in the current year and the most recent year:

(1) The Audit Committee and the Remuneration and Nomination Committee, composed entirely of independent directors, assist the Board of Directors in carrying out supervisory tasks. The chairperson of each committee reports on their committee’s operations to the board on a regular basis.

(2) "Rules of Procedures for Board of Directors Meeting" are adopted pursuant to the regulations of "Regulations Governing Procedure for Board of Directors Meetings of Public Companies" in the board of directors’ meeting of the Company.

(3) The Company provides its directors and managers with annual liability insurance to cover risks as they carry out their duties, and reviews the insurance coverage on an annual basis to make sure the amount and scope are sufficient to the need.

(4) Committed to upholding operational transparency and protection shareholders’ interests, the company's website has "Investor Zone", "Social Responsibility" and "Corporate Governance" to provide timely information regarding corporate governance, financial statements and investor conference in Chinese and English. Furthermore, important resolutions of the board of directors are announced after each board meeting is held. The Company also participate institutional investor conferences periodically.